Metabolic syndrome associated with hyperprolactinemia: a new indication for dopamine agonist treatment?
- PMID: 23975607
- DOI: 10.1007/s12020-013-9914-1
Metabolic syndrome associated with hyperprolactinemia: a new indication for dopamine agonist treatment?
Comment on
-
Effect of cabergoline on insulin sensitivity, inflammation, and carotid intima media thickness in patients with prolactinoma.Endocrine. 2013 Aug;44(1):193-9. doi: 10.1007/s12020-012-9857-y. Epub 2012 Dec 12. Endocrine. 2013. PMID: 23233277 Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
